Stock 2171 CARSGEN THERAPEUTICS HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials CARsgen Therapeutics Holdings Limited

Equities

2171

KYG1996C1006

Biotechnology & Medical Research

Delayed Hong Kong S.E.
Other stock markets
 01:38:20 14/05/2024 pm IST 		5-day change 1st Jan Change
6.16 HKD +1.65% Intraday chart for CARsgen Therapeutics Holdings Limited +4.76% -5.23%
30/04 CARsgen Therapeutics Holdings Limited Announces Abstracts from the Ongoing Studies of zevorcabtagene autoleucel and CT071 to be Presented as an Oral Presentation and a Poster Presentation, Respectively, at the Upcoming EHA 2024 CI
29/04 CARsgen Therapeutics Holdings Limited Announces Board and Committee Changes CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 12,717 7,576 3,401 3,283 - -
Enterprise Value (EV) 1 10,048 5,427 1,636 2,307 2,986 3,603
P/E ratio -1.83 x -8.17 x -4.41 x -4.74 x -4.55 x -9.99 x
Yield - - - - - -
Capitalization / Revenue 493 x - - 9.94 x 6.79 x 1.62 x
EV / Revenue 389 x - - 6.98 x 6.17 x 1.78 x
EV / EBITDA -19.2 x -7.39 x -2.32 x -3.46 x -4.52 x -15.2 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book 4.24 x 3.06 x 1.82 x 3.3 x 8.79 x 27.6 x
Nbr of stocks (in thousands) 5,67,537 5,72,625 5,75,640 5,75,644 - -
Reference price 2 22.41 13.23 5.908 5.703 5.703 5.703
Announcement Date 22/03/22 21/03/23 26/03/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 25.81 - - 330.3 483.7 2,026
EBITDA 1 -522.7 -734.6 -706 -667.4 -660.9 -237.8
EBIT 1 -575.2 -816.1 -793.3 -709.7 -712.4 -299.9
Operating Margin -2,228.18% - - -214.85% -147.28% -14.8%
Earnings before Tax (EBT) 1 -4,737 -891 -747.4 -680.3 -708 -320.4
Net income 1 -4,744 -892.2 -747.8 -680.3 -708 -320.4
Net margin -18,379.98% - - -205.94% -146.36% -15.82%
EPS 2 -12.26 -1.620 -1.340 -1.204 -1.254 -0.5709
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - - - - - -
Announcement Date 22/03/22 21/03/23 26/03/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 - 25.81 - - - - 245.3 84.98
EBITDA - - - - - - - -
EBIT 1 -213.2 -361.9 -379.3 -436.8 -385.6 -407.7 -167.5 -419.6
Operating Margin - -1,402.11% - - - - -68.29% -493.8%
Earnings before Tax (EBT) - - - - - - - -
Net income - - - - - - - -
Net margin - - - - - - - -
EPS 2 - 7.420 - -0.9300 -0.7300 -0.6100 -0.2600 -0.7200
Dividend per Share - - - - - - - -
Announcement Date 23/08/21 22/03/22 23/08/22 21/03/23 22/08/23 26/03/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 320
Net Cash position 1 2,669 2,149 1,765 976 297 -
Leverage (Debt/EBITDA) - - - - - -1.348 x
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) -83.1% -31% -35% -58.2% -90.8% -103%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 5.280 4.320 3.240 1.730 0.6500 0.2100
Cash Flow per Share - - - - - -
Capex 1 178 139 - 218 218 218
Capex / Sales 689.58% - - 66.01% 45.06% 10.76%
Announcement Date 22/03/22 21/03/23 26/03/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
5.703 CNY
Average target price
6.662 CNY
Spread / Average Target
+16.82%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
CARSGEN THERAPEUTICS HOLDINGS LIMITED Stock CARsgen Therapeutics Holdings Limited
-5.23% 45Cr
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+5.33% 11TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.11% 11TCr
BIONTECH SE Stock BioNTech SE
-12.56% 2.23TCr
ARGENX SE Stock argenx SE
-3.70% 2.19TCr
GENMAB A/S Stock Genmab A/S
-6.03% 1.86TCr
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-35.21% 1.81TCr
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.86% 1.7TCr
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.10% 1.37TCr
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.57% 1.24TCr
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 2171 Stock
  4. Financials CARsgen Therapeutics Holdings Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW